Longitudinal Construct Validity of the GMFM-88 Total Score and Goal Total Score and the GMFM-66 Score in a 5-Year Follow-up Study

Background: The Gross Motor Function Measure (GMFM) is the instrument most commonly used to measure gross motor function in children with cerebral palsy (CP). Different scoring options have been developed, and their measurement properties have been assessed. Limited information is available regarding longitudinal construct validity. Objective: The objective of this research was to study the longitudinal construct validity of 3 scoring options: the 88-item GMFM (GMFM-88) total, the GMFM-88 goal total, and the 66-item GMFM (GMFM-66). Design: A clinical measurement design was used in this study. Methods: Forty-one children with CP diplegia who were undergoing selective dorsal rhizotomy (SDR) were monitored with the GMFM for 5 years. The mean age at SDR was 4.4 years (range=2.5–6.6). Two subgroups for gross motor function before surgery were created according to the Gross Motor Function Classification System (GMFCS): GMFCS levels I to III and GMFCS levels IV and V. This study included results obtained before SDR and at 6, 12, and 18 months and 3 and 5 years after SDR. The effect size (ES) and the standardized response mean (SRM) were calculated. Results: At 6 months postoperatively, ES and SRM values were small (≤0.5) for all GMFM scoring options. The GMFM-88 total and goal total scores showed large changes in ES values (range=0.8–0.9) and SRM values (range=0.9–1.3) at 12 months postoperatively, whereas the GMFM-66 scores showed lower ES values (range=0.3–0.4) and SRM values (range=0.7–0.8) for both subgroups. Later postoperatively, larger values for longitudinal construct validity were found. The ES and SRM values generally were lower for the GMFM-66 scores than for the GMFM-88 total and goal total scores. Limitations: All children underwent an extensive intervention, and changes in gross motor function were expected. Conclusion: All 3 scoring options showed large longitudinal construct validity in the long-term follow-up. The GMFM-88 total and goal total scores revealed large changes in gross motor function earlier postoperatively than the GMFM-66 scores.

[1]  T. Lejeune,et al.  Experience with external pump trial prior to implantation for intrathecal baclofen in ambulatory patients with spastic cerebral palsy , 2007, Neurophysiologie Clinique/Clinical Neurophysiology.

[2]  Shao Xiao-mei,et al.  Reliability and Validity of the GMFM-66 in 0- to 3-Year-Old Children with Cerebral Palsy , 2006, American journal of physical medicine & rehabilitation.

[3]  J. Madsen,et al.  GMFM 1 year after continuous intrathecal baclofen infusion , 2005, Pediatric rehabilitation.

[4]  M. Ketelaar,et al.  Responsiveness of evaluative measures for children with cerebral palsy: The Gross Motor Function Measure and the Pediatric Evaluation of Disability Inventory , 2005, Disability and rehabilitation.

[5]  M. Benedetti,et al.  Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment. , 2003, Developmental medicine and child neurology.

[6]  C. Ekdahl,et al.  The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated health change after surgery , 2003, BMC musculoskeletal disorders.

[7]  C. Terwee,et al.  On assessing responsiveness of health-related quality of life instruments: Guidelines for instrument evaluation , 2003, Quality of Life Research.

[8]  P. Raina,et al.  Rasch analysis of the Gross Motor Function Measure: validating the assumptions of the Rasch model to create an interval-level measure. , 2003, Archives of physical medicine and rehabilitation.

[9]  P. Raina,et al.  Prognosis for gross motor function in cerebral palsy: creation of motor development curves. , 2002, JAMA.

[10]  J. Farmer,et al.  Long-term functional outcome after selective posterior rhizotomy. , 2002, Journal of neurosurgery.

[11]  A. Evans,et al.  Evaluation of the functional effects of a course of Bobath therapy in children with cerebral palsy: a preliminary study. , 2002, Developmental medicine and child neurology.

[12]  Virginia Knox MSc Mcsp,et al.  Evaluation of the functional effects of a course of Bobath therapy in children with cerebral palsy: a preliminary study , 2002 .

[13]  N. Temkin,et al.  Selective dorsal rhizotomy: meta‐analysis of three randomized controlled trials , 2002, Developmental medicine and child neurology.

[14]  J. Carlin,et al.  The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomized controlled trial , 2001, European journal of neurology.

[15]  P. Raina,et al.  Improved scaling of the gross motor function measure for children with cerebral palsy: evidence of reliability and validity. , 2000, Physical therapy.

[16]  M. Liang.  Longitudinal Construct Validity: Establishment of Clinical Meaning in Patient Evaluative Instruments , 2000, Medical care.

[17]  G. Hägglund,et al.  Comparison of the Gross Motor Function Measure and Paediatric Evaluation of Disability Inventory in assessing motor function in children undergoing selective dorsal rhizotomy , 2000, Developmental medicine and child neurology.

[18]  P. Stratford,et al.  Comparison of two outcome measures for infants with cerebral palsy and infants with motor delays. , 1998, Physical therapy.

[19]  R. Palisano,et al.  Development and reliability of a system to classify gross motor function in children with cerebral palsy , 1997, Developmental medicine and child neurology.

[20]  G. Hägglund,et al.  Reliability of the gross motor function measure in cerebral palsy. , 1997, Scandinavian journal of rehabilitation medicine.

[21]  D L Riddle,et al.  Health status measures: strategies and analytic methods for assessing change scores. , 1996, Physical therapy.

[22]  D. Cadman,et al.  THE GROSS MOTOR FUNCTION MEASURE: A MEANS TO EVALUATE THE EFFECTS OF PHYSICAL THERAPY , 1989, Developmental medicine and child neurology.

[23]  Thomas J. Kiresuk,et al.  Goal attainment scaling: A general method for evaluating comprehensive community mental health programs , 1968, Community Mental Health Journal.

[24]  Hui-Yi Wang,et al.  Evaluating the responsiveness of 2 versions of the gross motor function measure for children with cerebral palsy. , 2006, Archives of physical medicine and rehabilitation.

[25]  E. Finch.  Physical rehabilitation outcome measures : a guide to enhanced clinical decision making , 2002 .

[26]  A. P. Davis.  Comparison of the gross motor function measure and paediatric evaluation of disability inventory in assessing motor function in children undergoing selective dorsal rhizotomy. , 2001, Pediatric Physical Therapy.

[27]  K. Bjornson,et al.  Test-retest reliability of the gross motor function measure in children with cerebral palsy. , 2000, Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association.

[28]  W. Peacock,et al.  Cerebral palsy spasticity. Selective posterior rhizotomy. , 1987, Pediatric neuroscience.